182 related articles for article (PubMed ID: 19415689)
1. Increased bone resorption and osteopenia in Dlx5 heterozygous mice.
Samee N; Geoffroy V; Marty C; Schiltz C; Vieux-Rochas M; Clément-Lacroix P; Belleville C; Levi G; de Vernejoul MC
J Cell Biochem; 2009 Aug; 107(5):865-72. PubMed ID: 19415689
[TBL] [Abstract][Full Text] [Related]
2. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
3. Bone density, strength, and formation in adult cathepsin K (-/-) mice.
Pennypacker B; Shea M; Liu Q; Masarachia P; Saftig P; Rodan S; Rodan G; Kimmel D
Bone; 2009 Feb; 44(2):199-207. PubMed ID: 18845279
[TBL] [Abstract][Full Text] [Related]
4. Femoral peak bone mass and osteoclast number in an animal model of age-related spontaneous osteopenia.
Okamoto Y; Takahashi K; Toriyama K; Takeda N; Kitagawa K; Hosokawa M; Takeda T
Anat Rec; 1995 May; 242(1):21-8. PubMed ID: 7604978
[TBL] [Abstract][Full Text] [Related]
5. Bone has a sexually dimorphic response to aromatase deficiency.
Oz OK; Zerwekh JE; Fisher C; Graves K; Nanu L; Millsaps R; Simpson ER
J Bone Miner Res; 2000 Mar; 15(3):507-14. PubMed ID: 10750565
[TBL] [Abstract][Full Text] [Related]
6. Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.
Samee N; Geoffroy V; Marty C; Schiltz C; Vieux-Rochas M; Levi G; de Vernejoul MC
Am J Pathol; 2008 Sep; 173(3):773-80. PubMed ID: 18669617
[TBL] [Abstract][Full Text] [Related]
7. Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.
Günther T; Poli C; Müller JM; Catala-Lehnen P; Schinke T; Yin N; Vomstein S; Amling M; Schüle R
EMBO J; 2005 Sep; 24(17):3049-56. PubMed ID: 16079911
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice.
Sobue T; Naganawa T; Xiao L; Okada Y; Tanaka Y; Ito M; Okimoto N; Nakamura T; Coffin JD; Hurley MM
J Cell Biochem; 2005 May; 95(1):83-94. PubMed ID: 15723277
[TBL] [Abstract][Full Text] [Related]
9. HLA-B27 rats develop osteopaenia through increased bone resorption without any change in bone formation.
Papet I; El Yousfi M; Godin JP; Mermoud AF; Davicco MJ; Coxam V; Breuille D; Obled C
J Musculoskelet Neuronal Interact; 2008; 8(3):251-6. PubMed ID: 18799858
[TBL] [Abstract][Full Text] [Related]
10. Postnatal growth and bone mass in mice with IGF-I haploinsufficiency.
He J; Rosen CJ; Adams DJ; Kream BE
Bone; 2006 Jun; 38(6):826-35. PubMed ID: 16427371
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone.
Salie R; Kneissel M; Vukevic M; Zamurovic N; Kramer I; Evans G; Gerwin N; Mueller M; Kinzel B; Susa M
Bone; 2010 Mar; 46(3):680-94. PubMed ID: 19857617
[TBL] [Abstract][Full Text] [Related]
12. Lower bone cellular activities in male and female mature C3H/HeJ mice are associated with higher bone mass and different pyridinium crosslink profiles compared to C57BL/6J mice.
Amblard D; Lafage-Proust MH; Chamson A; Rattner A; Collet P; Alexandre C; Vico L
J Bone Miner Metab; 2003; 21(6):377-87. PubMed ID: 14586794
[TBL] [Abstract][Full Text] [Related]
13. Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts.
Kawamata A; Inoue A; Miyajima D; Hemmi H; Mashima R; Hayata T; Ezura Y; Amagasa T; Yamanashi Y; Noda M
J Cell Physiol; 2011 Dec; 226(12):3087-93. PubMed ID: 21732353
[TBL] [Abstract][Full Text] [Related]
14. Osteopetrosis-like phenotype in latent TGF-beta binding protein 3 deficient mice.
Dabovic B; Levasseur R; Zambuto L; Chen Y; Karsenty G; Rifkin DB
Bone; 2005 Jul; 37(1):25-31. PubMed ID: 15878314
[TBL] [Abstract][Full Text] [Related]
15. Combinatory effects of androgen receptor deficiency and hind limb unloading on bone.
Saita Y; Nakamura T; Mizoguchi F; Nakashima K; Hemmi H; Hayata T; Ezura Y; Kurosawa H; Kato S; Noda M
Horm Metab Res; 2009 Nov; 41(11):822-8. PubMed ID: 19629928
[TBL] [Abstract][Full Text] [Related]
16. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
[TBL] [Abstract][Full Text] [Related]
17. COX-2 is necessary for venous ligation-mediated bone adaptation in mice.
Stevens HY; Meays DR; Yeh J; Bjursten LM; Frangos JA
Bone; 2006 Jan; 38(1):93-104. PubMed ID: 16122997
[TBL] [Abstract][Full Text] [Related]
18. Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss.
Mizoguchi F; Mizuno A; Hayata T; Nakashima K; Heller S; Ushida T; Sokabe M; Miyasaka N; Suzuki M; Ezura Y; Noda M
J Cell Physiol; 2008 Jul; 216(1):47-53. PubMed ID: 18264976
[TBL] [Abstract][Full Text] [Related]
19. Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice.
Kalak R; Zhou H; Street J; Day RE; Modzelewski JR; Spies CM; Liu PY; Li G; Dunstan CR; Seibel MJ
Bone; 2009 Jul; 45(1):61-7. PubMed ID: 19358901
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
